New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Progenics Pharmaceuticals, Inc (NASDAQ:PGNX), RiceBran Technologies (NASDAQ:RIBT), DragonWave, Inc (USA)(NASDAQ:DRWI), Idenix Pharmaceuticals Inc (NASDAQ:IDIX)
Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) showed a volume of 1.01 million shares by the end of last trade whereas the average volume of the stock remained 1.12 million shares. The stock opened the session at $6.66 but then moved to $6.89. At that price, the stock showed a positive performance of 2.84%. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways in the growth of aggressive cancers.
Will PGNX Continue To Move Higher? Find Out Here
RiceBran Technologies (NASDAQ:RIBT) opened the session at $6.78 and closed the session at $6.10. The stock showed a negative performance of -0.81% in previous trading session. RiceBran Technologies, formerly NutraCea is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. The Company has developed a bio-refining approach to processing raw rice bran into various constituents, such as stabilized rice bran (SRB), rice bran oil (RBO),
Has RIBT Found The Bottom And Ready To Gain Momentum? Find Out Here
DragonWave, Inc (USA)(NASDAQ:DRWI) opened the session at $1.75 and closed the session at $1.73. The stock showed a negative performance of -1.14% in previous trading session. The beta of the stock remained 1.46. DragonWave Inc. (DragonWave) is in the business of developing broadband wireless backhaul and pseudowire equipment. The Company is a provider of wireless Ethernet equipment used in Internet protocol (IP) networks. DragonWave designs, develops, markets and sells carrier-grade microwave radio frequency networking equipment (referred to as links),Why Should Investors Buy DRWI After the Recent Fall? Just Go Here and Find Out
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) the stock decreased -1.87% and finished the session at $6.84. Traded with volume of 1.00 million shares in the prior session and the average volume of the stock remained 1.17 million shares. The beta of the stock remained 0.44. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. As of December 31, 2012, the Company's primary research and development focused on the treatment of patients with hepatitis C virus (HCV).
Will IDIX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)